Literature DB >> 8253555

Assessment of quality of life in head and neck cancer patients.

S J Hassan1, E A Weymuller.   

Abstract

UNLABELLED: Seventy-five consecutive patients were selected to evaluate a disease-specific quality-of-life questionnaire (UW QOL). The new test was compared to two established equality of life evaluation tools, the Karnofsky scale and the Sickness Impact Profile (SIP). Each test was administered on three separate occasions: (1) several days preoperatively; (2) immediately postoperatively; and (3) 3 months postoperatively. The Karnofsky scale is relatively crude and lacks the ability to measure subtle changes. The SIP is a detailed questionnaire that is quite sensitive to change. However, due to its length, the SIP is inefficient and expensive to administer, and patient non-compliance is often a problem. The three questionnaires were compared according to the following factors: Acceptability: 97% of the patients favored the UW QOL scale compared with the SIP because it was more concise and easier to complete. VALIDITY: VALIDITY indicates the ability of the test under investigation to measure what it was intended to measure. Using the SIP as a gold standard, the UW QOL scale demonstrated an average criterion validity of 0.849, whereas the Karnofsky average criterion validity was 0.826. Reliability: Reliability is a measurement of the reproducibility of the data. The UW QOL questionnaire scored > 0.90 on reliability coefficients versus 0.80 for the Karnofsky and 0.87 for the SIP scale. Responsiveness: Responsiveness is the ability of the test to measure clinical change. The UW QOL scale faired better than the Karnofsky and the SIP scale in detecting change. The UW QOL scale is comparable to the Karnofsky and SIP scales when tested for validity and reliability. It was the preferred test format of 97% of patients and provided the greatest responsiveness to clinical change.

Entities:  

Mesh:

Year:  1993        PMID: 8253555     DOI: 10.1002/hed.2880150603

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  92 in total

1.  Omitting the lower neck and sparing the glottic larynx in node-negative nasopharyngeal carcinoma was safe and feasible, and improved patient-reported voice outcomes.

Authors:  F Xiao; S Dou; Y Li; W Qian; F Liang; L Kong; X Wang; K Wu; C Hu; G Zhu
Journal:  Clin Transl Oncol       Date:  2018-12-04       Impact factor: 3.405

2.  Psychometric testing of the Chinese-version cancer needs questionnaire short form head and neck cancer-specific version in oral cavity cancer patients.

Authors:  Shu-Ching Chen; Yeur-Hur Lai; Sue-Yueh Cheng; Chun-Ta Liao; Joseph Tung-Chien Chang
Journal:  Support Care Cancer       Date:  2010-04-28       Impact factor: 3.603

3.  Coping and quality of life after total laryngectomy.

Authors:  Tanya L Eadie; Brianne C Bowker
Journal:  Otolaryngol Head Neck Surg       Date:  2012-02-03       Impact factor: 3.497

4.  The impact of taste and smell alterations on quality of life in head and neck cancer patients.

Authors:  M Alvarez-Camacho; S Gonella; S Ghosh; C Kubrak; R A Scrimger; K P Chu; W V Wismer
Journal:  Qual Life Res       Date:  2015-11-20       Impact factor: 4.147

5.  Trends in the 15D health-related quality of life over the first year following diagnosis of head and neck cancer.

Authors:  K Aro; L Bäck; V Loimu; K Saarilahti; S Rogers; H Sintonen; R Roine; Antti Mäkitie
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-07-28       Impact factor: 2.503

6.  Long-term quality of life after swallowing and salivary-sparing chemo-intensity modulated radiation therapy in survivors of human papillomavirus-related oropharyngeal cancer.

Authors:  Jeffrey M Vainshtein; Dominic H Moon; Felix Y Feng; Douglas B Chepeha; Avraham Eisbruch; Matthew H Stenmark
Journal:  Int J Radiat Oncol Biol Phys       Date:  2015-04-01       Impact factor: 7.038

Review 7.  A framework for assessment in oncology rehabilitation.

Authors:  Laura S Gilchrist; Mary Lou Galantino; Meredith Wampler; Victoria G Marchese; G Stephen Morris; Kirsten K Ness
Journal:  Phys Ther       Date:  2009-01-15

8.  MRI-guided radiotherapy for head and neck cancer: initial clinical experience.

Authors:  A M Chen; S Hsu; J Lamb; Y Yang; N Agazaryan; M L Steinberg; D A Low; M Cao
Journal:  Clin Transl Oncol       Date:  2017-06-13       Impact factor: 3.405

Review 9.  Psychosocial Issues in Patients with Head and Neck Cancer: an Updated Review with a Focus on Clinical Interventions.

Authors:  Joshua D Smith; Andrew G Shuman; Michelle B Riba
Journal:  Curr Psychiatry Rep       Date:  2017-09       Impact factor: 5.285

10.  Patient-Reported Quality-of-Life Outcome Measures in the Thyroid Cancer Population.

Authors:  Eve M Roth; Carrie C Lubitz; John Shannon Swan; Benjamin C James
Journal:  Thyroid       Date:  2020-05-14       Impact factor: 6.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.